Biomedical Engineering Reference
In-Depth Information
363. Aronica E, Gorter JA, Jansen GH, van Veelen CW, van Rijen PC, Leenstra S, Ramkema
M, Scheffer GL, Scheper RJ, Troost D. 2003. Expression and cellular distribution of
multidrug transporter proteins in two major causes of medically intractable epilepsy:
focal cortical dysplasia and glioneuronal tumors. Neuroscience 118:417-429.
364. Vogelgesang S, Kunert-Keil C, Cascorbi I, Mosyagin I, Schroder E, Runge U, Jedlitschky
G, Kroemer HK, Oertel J, Gaab MR, et al. 2004. Expression of multidrug transporters in
dysembryoplastic neuroepithelial tumors causing intractable epilepsy. Clin Neuropathol
23:223-231.
365. Benveniste EN, Nguyen VT, O'Keefe GM. 2001. Immunological aspects of microglia:
relevance to Alzheimer's disease. Neurochem Int 39:381-391.
366. Giulian D. 1999. Microglia and the immune pathology of Alzheimer disease. Am J Hum
Genet 65:13-18.
367. Cummings JL, Vinters HV, Cole GM, Khachaturian ZS. 1998. Alzheimer's disease:
etiologies, pathophysiology, cognitive reserve, and treatment opportunities. Neurology
51:S2-S17.
368. Lam FC, Liu R, Lu P, Shapiro AB, Renoir JM, Sharom FJ, Reiner PB. 2001. beta-Amyloid
efflux mediated by P-glycoprotein. J Neurochem 76:1121-1128.
369. Vogelgesang S, Warzok RW, Cascorbi I, Kunert-Keil C, Schroeder E, Kroemer HK,
Siegmund W, Walker LC, Pahnke J. 2004. The role of P-glycoprotein in cerebral
amyloid angiopathy; implications for the early pathogenesis of Alzheimer's disease.
Curr Alzheimer Res 1:121-125.
370. Fassbender K, Simons M, Bergmann C, Stroick M, Lutjohann D, Keller P, Runz H,
Kuhl S, Bertsch T, von Bergmann K, et al. 2001. Simvastatin strongly reduces levels of
Alzheimer's disease beta-amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo.
Proc Natl Acad SciUSA98:5856-5861.
371. Ben Shlomo Y, Sieradzan K. 1995. Idiopathic Parkinson's disease: epidemiology,
diagnosis and management. Br J Gen Pract 45:261-268.
372. Koller W, Vetere-Overfield B, Gray C, Alexander C, Chin T, Dolezal J, Hassanein R, Tan-
ner C. 1990. Environmental risk factors in Parkinson's disease. Neurology 40:1218-1221.
373. Semchuk KM, Love EJ, Lee RG. 1992. Parkinson's disease and exposure to agricultural
work and pesticide chemicals. Neurology 42:1328-1335.
374. Schinkel AH, Wagenaar E, Mol CA, van Deemter L. 1996. P-Glycoprotein in the
blood-brain barrier of mice influences the brain penetration and pharmacological activity
of many drugs. J Clin Invest 97:2517-2524.
Search WWH ::
Custom Search